Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
European Endocrinology|October 24, 2018
Extra-hepatic AcromegalySanne E Franck, Aart Jan van der Lely, Sebastian NeggersNeuroendocrinology|August 12, 2016
The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-AnalysisSanne E Franck, Linda Broer, Aart Jan van der Lely, et al.The Journal of Clinical Endocrinology and Metabolism|October 23, 2018
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 ExpressionAmmar Muhammad, Eva C Coopmans, Federico Gatto, et al.Neuroendocrinology|July 26, 2016
Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with PegvisomantSanne E Franck, Federico Gatto, Aart Jan van der Lely, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary AdenomasFederico Gatto, Richard A Feelders, Sanne E Franck, et al.European Journal of Endocrinology|July 27, 2022
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation studyClaudia Campana, Peter M van Koetsveld, Richard A Feelders, et al.Pageof 1